Salvage treatment options for prostate cancer after the failure of radiation as a primary treatment is often seen as a reason to avoid radiation as a primary treatment modality. The common collective wisdom is that after failed radiation our options for additional treatment of recurrent prostate cancer are limited to systematic treatments, hormone therapy, Ketoconazole [...]
HIFU is becoming increasing popular as a primary alternative treatment for men diagnosed with prostate cancer that is confined in the gland. Commonly used in Europe and in Mexico, HIFU is also being evaluated in a clinical trials in the United States. As with all primary prostate cancer treatments, it too has a failure rate. [...]
CAUTION, some doctors use estrogen patches as a form of first line hormone blockade therapy for the treatment of prostate cancer. However, scientists from Weill Cornell Medical College, New York City have described the hormone estrogen as a potential key negative player in about half of all prostate cancers. Researchers have found that Estrogen-linked signaling [...]
Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients with incontinence resulting from iatrogenic sphincter damage may benefit from stem cell therapy. Incontinence after a radical prostatectomy for the treatment of prostate cancer can be a result in damage to the external urinary sphincter and would [...]
The FDA has announced its conditional approval, pending minor changes to the protocol, for a clinical trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 (HIFU) in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine will serve as the medical monitor [...]
I have been very negligent in not writing about my experience at the American Association of Cancer Researchers (AACR) annual meeting that I attended last month. I found that there was so much information, experiences and emotions that I came away feeling very awed and somewhat over whelmed by the experience. I am still [...]
Susan G. Komen for the Cure CEO Hala Moddelmog testified before a special hearing of the Senate Committee on Health, Education, Labor and Pensions on the need for comprehensive legislation to address the nation's cancer crisis. Along with Moddeling at the committee meeting was Elizabeth Edwards and Lance Armstrong. Moddeling, in her testimony, emphasized the [...]
Prostate cancer preferentially metastasizes to bone and the mortality from prostate cancer is 70% once bone metastases are present. In addition, prostate cancer-induced bone metastases are associated with significant complications including severe pain, skeletal fractures, spinal cord compression and bone marrow suppression. Most doctors structure their treatment protocols against bone metastases by treating the cancer [...]
Watson Pharmaceuticals, Inc. (WPI), announced that the U.S. Food and Drug Administration (FDA) has approved MIXJECT, which is a new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension). The delivery system includes some new features, a smaller 21-gauge needle that should improve comfort and a shield covering the needle both before and after drug [...]
Are you taking Fosamax to help combat osteoporosis? Many of us take Fosamax as one of the most common side effects of a hormone blockade (ADT) is loss of bone density. ADT causes osteoporosis, or a decrease in bone density, which diminishes bone strength. A decrease in your bone density increases your chance to suffer [...]
